Link to this page
National Drug File - Reference Terminology
Last uploaded:
July 6, 2018
Jump to:
Preferred Name | Prazosin [Chemical/Ingredient] | |
Synonyms |
Prazosin Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)- Furazosin |
|
ID |
http://purl.bioontology.org/ontology/NDFRT/N0000006638 |
|
altLabel |
Prazosin Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)- Furazosin
|
|
cui |
C0032912
|
|
Ingredient of |
http://purl.bioontology.org/ontology/NDFRT/N0000020837 http://purl.bioontology.org/ontology/NDFRT/N0000154868 http://purl.bioontology.org/ontology/NDFRT/N0000154867 http://purl.bioontology.org/ontology/NDFRT/N0000161731 http://purl.bioontology.org/ontology/NDFRT/N0000147152 http://purl.bioontology.org/ontology/NDFRT/N0000154869 http://purl.bioontology.org/ontology/NDFRT/N0000164102 |
|
MESH DEFINITION |
A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
|
|
MESH DUI |
D011224
|
|
MeSH name |
Prazosin
|
|
MESH UI |
M0017441
|
|
NDFRT kind |
INGREDIENT_KIND
|
|
notation |
N0000006638
|
|
NUI |
N0000006638
|
|
prefLabel |
Prazosin [Chemical/Ingredient]
|
|
tui |
T109 T121
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping